Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Nihon Nohyaku Co., Ltd. has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 distinct examiners across 3 distinct art units, indicating examiner-specific prosecution with some art-unit overlap. Counsel can use shared technical guidance for recurring biotechnology or pharmaceutical concepts, while tailoring each response to the assigned examination context.
MARTIN, KEVIN STEPHEN is the busiest examiner, with 1 pending matter. No examiner accounts for a concentrated portion of the identified docket, so consistent internal review and application-specific analysis should guide prosecution. Particular attention to biological support, pharmaceutical distinctions, and the relationship between claim language and disclosure can improve response precision.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARTIN, KEVIN STEPHEN | 1 | 77.4% | +23.3% |
| KIFLE, BRUCK | 1 | 79.3% | +15.8% |
| TICHY, JENNIFER M.H. | 1 | 64.6% | +34.4% |
| SHOWALTER, ALEXANDER KEITH | 1 | 55.4% | +27.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566534 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | SHOWALTER, ALEXANDER KEITH | 9d |
| 18845166 | PIPERIDINONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | MARTIN, KEVIN STEPHEN | — |
| 18725648 | ARYL CYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | KIFLE, BRUCK | — |
| 18389620 | MICROBIAL COMPOSITIONS FOR USE WITH PLANTS FOR THE PREVENTION OR REDUCTION OF FUNGAL PATHOGENS | TICHY, JENNIFER M.H. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566534 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | SHOWALTER, ALEXANDER KEITH | 9d |
| 18845166 | PIPERIDINONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | MARTIN, KEVIN STEPHEN | — |
| 18725648 | ARYL CYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | KIFLE, BRUCK | — |
| 18389620 | MICROBIAL COMPOSITIONS FOR USE WITH PLANTS FOR THE PREVENTION OR REDUCTION OF FUNGAL PATHOGENS | TICHY, JENNIFER M.H. | — |
| Art Unit | Apps |
|---|---|
| 1624 | 2 |
| 1653 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18845166 | PIPERIDINONE DERIVATIVE OR SALT THEREOF, HARMFUL ORGANISM CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME | MARTIN, KEVIN STEPHEN | 1624 | §101§112 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18725648 | ARYL CYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF | KIFLE, BRUCK | 1624 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18389620 | MICROBIAL COMPOSITIONS FOR USE WITH PLANTS FOR THE PREVENTION OR REDUCTION OF FUNGAL PATHOGENS | TICHY, JENNIFER M.H. | 1653 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18566534 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | SHOWALTER, ALEXANDER KEITH | 1629 | §102§112 | Non-Final OA | 9d | Pending | Dec 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNihon Nohyaku Co., Ltd. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Kevin Stephen Martin has the most, with 1 of Nihon Nohyaku Co., Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
